Home Ingredients inavea™ CINNAMON ACACIA
Metabolic HealthCardiovascular

inavea™ CINNAMON ACACIA

Evidence Level
Moderate
2 Clinical Trials
6 Documented Benefits
3/5 Evidence Score

inavea™ cinnamon acacia is an organic synergistic formulation developed by Nexira (France) — combining cinnamon (Cinnamomum verum / cassia) and acacia gum for metabolic health applications. Distinguished by in vivo demonstrated glycemia and insulinemia improvement, prebiotic activity at 5 g/day, role in metabolic health under high-fat-high-sucrose dysbiosis conditions, increased SCFA production (propionate and butyrate), and carbon neutral organic certification. Combines cinnamon's polyphenols (PACs) with acacia's prebiotic fiber for dual mechanism metabolic support.

Studied Dose 5 g/day (research-validated dose)
Active Compound Cinnamon polyphenols (PACs, polyphenols) + Acacia gum prebiotic fiber

Benefits

Glycemia and Insulinemia Improvement

Nexira in vivo study (high fat/sucrose diet model) showed inavea™ cinnamon acacia improves blood glucose and insulin markers vs HFHS-induced dysbiosis controls. Mechanism: cinnamon glucose modulation + acacia prebiotic effects.

Supported by Trial 1

Strong Prebiotic Activity

Significant ability to modulate overall gut microbiota population at 5 g/day; promotion of beneficial bacteria including Parabacteroides distasonis (whose benefits on metabolic health markers like glycemia and weight have been substantiated by Wang 2019 and others).

Supported by Trial 1

Increased SCFA Production (Propionate and Butyrate)

Specifically increases propionate and butyrate (SCFAs with metabolic health benefits) — propionate supports gluconeogenesis modulation and satiety; butyrate is colonocyte fuel and has insulin-sensitizing effects.

Supported by Trial 1

Microbiome Modulation Under Metabolic Stress

Studied specifically under dysbiosis-inducing conditions (high fat / high sucrose diet) — demonstrates effects in challenging metabolic environments. Relevant to: Western diet patterns, prediabetes, metabolic syndrome contexts.

Supported by Trial 1

Dual Mechanism (Polyphenols + Fiber)

Combines cinnamon polyphenols (direct insulin-mimetic and antioxidant effects) with acacia prebiotic fiber (indirect microbiome-mediated metabolic effects). Distinct mechanisms with complementary metabolic benefits.

Supported by Trial 1

Subtle Cinnamon Taste

Pleasant warming cinnamon flavor; suitable for: warm beverages, baked goods, breakfast applications, functional shots.

Supported by Trial 1, Trial 2

Mechanism of action

1

Cinnamon Polyphenol Metabolic Effects

Cinnamon contains polyphenols including proanthocyanidins (PACs), CINNAMTANNINS (B-type PACs unique to cinnamon), and other polyphenols. Mechanisms: insulin-mimetic effects (insulin receptor stimulation), enhanced glucose uptake in muscle/adipose, modulation of carbohydrate digestion enzymes.

2

Acacia Prebiotic Mechanism

Acacia gum supports beneficial bacteria, SCFA production, gut barrier — see acacia/Fibregum entries. Foundation for indirect metabolic benefits.

3

Parabacteroides distasonis Promotion

Specific bacterial species shown to support metabolic health markers (glycemia, weight); inavea™ cinnamon acacia selectively promotes this beneficial species.

4

Propionate/Butyrate Specificity

Among SCFAs, propionate and butyrate are particularly metabolically active — increased production from this formulation supports specific metabolic health pathways.

Clinical trials

1
inavea™ cinnamon acacia Metabolic Health — Nexira In Vivo Study

In vivo study of inavea™ cinnamon acacia in high fat/high sucrose diet-induced dysbiosis model.

In vivo model under metabolic stress conditions.

Strong prebiotic activity, synergistic gut microbiome balance contribution, significant role in metabolic health improvement (glycemia and insulinemia).

2
Cinnamon for Glycemic Control

Trial of cinnamon on glycemic markers in T2D patients.

T2D patients.

Cinnamon reduced fasting glucose and HbA1c. Established cinnamon-specific glycemic effects (foundation for combination formulations).

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated.
Mild GI distress with rapid introduction.
Coumarin content concern (cassia cinnamon) — Nexira specifies low coumarin content.
Allergic reactions to cinnamon rare.
Mouth/throat irritation from concentrated cinnamon possible.
Hepatotoxicity from very high cassia cinnamon intake (coumarin) — concern at very high doses; product designed for safe use.

Important Drug interactions

Diabetes medications — additive hypoglycemic effects from cinnamon; modest concern; monitor glucose.
Anticoagulants — coumarin in cassia cinnamon has theoretical anticoagulant effect; choose Ceylon cinnamon products if possible; modest concern.
Hepatotoxic medications — additive concern at very high doses (coumarin).
Pregnancy — moderate cinnamon culinary use safe; concentrated supplementation limited safety data; avoid high-dose supplementation.
Lactation — moderate use safe; high-dose supplementation limited data.

More Metabolic Health Ingredients

Metabolic Health
Psyllium Husk (Plantago ovata)
Psyllium husk is the soluble fiber derived from the seed husks of Plantago ovata — the mos…
Metabolic Health
Thiamine
Thiamine, also known as vitamin B1, is a water-soluble vitamin essential for converting ca…
Metabolic Health
Berberine
Berberine is a bioactive compound extracted from plants like barberry and goldenseal, know…
Metabolic Health
Inositol (Myo-Inositol)
Inositol is a naturally occurring sugar alcohol that acts as a secondary messenger in insu…

Explore Other Ingredients

Cognitive
Rhodiola Rosea
Rhodiola rosea is an adaptogenic herb traditionally used in cold northern regions to comba…
Cognitive
Suntheanine®
Suntheanine® is a patented, 100% pure L-isomer theanine produced via an enzymatic process…
Muscle & Recovery
L-Glutamine
L-glutamine is the most abundant amino acid in the body and the primary metabolic fuel for…

Frequently asked questions about inavea™ CINNAMON ACACIA

What is inavea CINNAMON ACACIA?

inavea™ cinnamon acacia is an organic synergistic formulation developed by Nexira (France) — combining cinnamon (Cinnamomum verum / cassia) and acacia gum for metabolic health applications.

What is inavea CINNAMON ACACIA used for?

inavea CINNAMON ACACIA is researched primarily for Metabolic Health and Cardiovascular. Nexira in vivo study (high fat/sucrose diet model) showed inavea™ cinnamon acacia improves blood glucose and insulin markers vs HFHS-induced dysbiosis controls. Mechanism: cinnamon glucose modulation + acacia prebiotic effects.

What is the recommended dosage of inavea CINNAMON ACACIA?

The clinically studied dose is 5 g/day (research-validated dose) Always follow the product label and check with a healthcare provider for personal advice.

Is inavea CINNAMON ACACIA safe, and does it have side effects?

For most healthy adults, inavea CINNAMON ACACIA is well tolerated at studied doses. Reported effects can include: Generally well-tolerated. Mild GI distress with rapid introduction. It may also interact with some medications. inavea CINNAMON ACACIA is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does inavea CINNAMON ACACIA interact with any medications?

Possible interactions include: Diabetes medications — additive hypoglycemic effects from cinnamon; modest concern; monitor glucose. Anticoagulants — coumarin in cassia cinnamon has theoretical anticoagulant effect; choose Ceylon cinnamon products if possible; modest concern. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for inavea CINNAMON ACACIA?

NutraSmarts rates the evidence for inavea CINNAMON ACACIA as Moderate (3 out of 5). It is backed by 2 clinical trials and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Kutbi EH, Sohouli MH, Fatahi S, Lari A, Shidfar F, Aljhdali MM, Alhoshan FM, Elahi SS, Almusa HA, Abu-Zaid A The beneficial effects of cinnamon among patients with metabolic diseases: A systematic review and dose-response meta-analysis of randomized-controlled trials. Crit Rev Food Sci Nutr. 2022;62(22):6113-6131. doi: 10.1080/10408398.2021.1896473.PubMedUsed to support: Dose-response meta-analysis of 35 RCTs showing cinnamon supplementation ≤1.5 g/day significantly reduces fasting serum glucose (WMD −11.39 mg/dL, p<0.001) and insulin (WMD −1.27 μIU/mL, p=0.028) in metabolic disease patients. Directly supports the 'Glycemia and Insulinemia Improvement' and 'Dual Mechanism' claims for the cinnamon component. Note: evidence is on cinnamon as a component, not the inavea cinnamon-acacia blend per se.
  2. Jarrar AH, Stojanovska L, Apostolopoulos V, Feehan J, Bataineh MF, Ismail LC, Al Dhaheri AS The Effect of Gum Arabic (Acacia Senegal) on Cardiovascular Risk Factors and Gastrointestinal Symptoms in Adults at Risk of Metabolic Syndrome: A Randomized Clinical Trial. Nutrients. 2021;13(1):194. doi: 10.3390/nu13010194.PubMedUsed to support: Human RCT (n=61) showing gum arabic (acacia) improves gastrointestinal function and metabolic markers in adults at metabolic syndrome risk. Supports the 'Strong Prebiotic Activity' and 'Microbiome Modulation Under Metabolic Stress' claims for the acacia component of the blend.
  3. Alarifi S, Bell A, Walton G In vitro fermentation of gum acacia - impact on the faecal microbiota. Int J Food Sci Nutr. 2018;69(6):696-704. doi: 10.1080/09637486.2017.1404970.PubMedUsed to support: In vitro fermentation study showing gum acacia increases propionate and butyrate production alongside Bifidobacterium enrichment. Supports the 'Increased SCFA Production (Propionate and Butyrate)' claim for the acacia component of inavea cinnamon acacia.
  4. Kirkham S, Akilen R, Sharma S, Tsiami A The potential of cinnamon to reduce blood glucose levels in patients with type 2 diabetes and insulin resistance. Diabetes Obes Metab. 2009;11(12):1100-13. doi: 10.1111/j.1463-1326.2009.01094.x.PubMedUsed to support: Review of 8 RCTs of Cinnamomum cassia and C. verum showing antihyperglycaemic effects and reduced postprandial blood glucose (up to 18-29% in some diabetic trials). Supports the 'Glycemia and Insulinemia Improvement' and 'Dual Mechanism (Polyphenols + Fiber)' claims for the cinnamon component.